News
Industry updates and the latest news
Jul
Complete Guide to the Four Major Efficacy Mechanisms of the Peptide Family: How to Select the Right Raw Materials by "Mechanism of Action" for Cosmetic OEM (with Selection Decision Table)
Jul
Oligopeptide-1 and Human Oligopeptide-1 are not the same — 2 INCI naming pitfalls that cosmetic OEMs must understand (with a compliance checklist attached)
Jul
Beijing's First Professional Claim Extortion Case: 1118 Split Orders, 470K RMB Claim - What Compliant Companies Need to Know
Jul
Perawang and Juzi Biotech are both locking down raw materials — the windfall for peptide contract manufacturing has arrived.
Jul
Behind Vicky's listing: What are the new standards for brands choosing contract manufacturers?
Jul
Vicky Technology surged 600% on its first day of listing, ushering in a golden window for the peptide CDMO sector.
Jul
On July 19, 2026, the new revision of the EU MDR officially takes effect: 3 new opportunities for Chinese Class II medical device OEM companies going global (practical pitfall-avoidance edition)
Jul
It has been 12 days since 5 categories of new cosmetic ingredients were removed from the "high-risk" list: 3 real changes in the formulation development paths for OEM/ODM companies
Jul
2026 Cosmetic Classification Rules and Efficacy Claim Compliance Key Points: A Practical Pitfall-Avoidance Guide That Brands Must Read
Jul
